NKE
36
2
PSX
24
2
UPS
51
6
ABT
54
4
CMI
49
2
RF
44
10
GD
42
4
HUM
25
4
STX
34
2
MTB
38
4
MRK
25
2
TRV
34
4
ACN
54
2
FIS
43
5
GWW
50
9
MMC
46
5
SIG
52
5
JNJ
30
4
UAL
73
3
ROST
60
3
NKE
36
2
PSX
24
2
UPS
51
6
ABT
54
4
CMI
49
2
RF
44
10
GD
42
4
HUM
25
4
STX
34
2
MTB
38
4
MRK
25
2
TRV
34
4
ACN
54
2
FIS
43
5
GWW
50
9
MMC
46
5
SIG
52
5
JNJ
30
4
UAL
73
3
ROST
60
3
Financhill
Back

EyePoint Pharmaceuticals Vs. Novo Nordisk AS Industry Stock Comparison

Sell
33

EYPT
EyePoint Pharmaceuticals

Last Price:
$7.12
Seasonality Move:
7.64%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
33
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $7.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: -639404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.76 - 9.04) Sell
Bollinger Bands (100): (7.84 - 10.36) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.62 Sell
20-day SMA: 8.29 Sell
50-day SMA: 9.7 Sell
200-day SMA: 11.63 Sell
8-day EMA: 7.61 Sell
20-day EMA: 8.25 Sell
50-day EMA: 8.98 Sell
200-day EMA: 10.9 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):